发明名称 |
Use of soluble fgl2 as an immunosuppressant |
摘要 |
Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies.
|
申请公布号 |
US7632495(B2) |
申请公布日期 |
2009.12.15 |
申请号 |
US20050504328 |
申请日期 |
2005.03.11 |
申请人 |
VERITAS THERAPEUTICS INC. |
发明人 |
LEVY GARY |
分类号 |
A61K39/395;A61K38/18;A61K38/36;A61K38/48;A61K39/00;A61P37/06;C07K16/00;C12N9/64 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|